Paul Jackson

2.6k total citations
43 papers, 1.7k citations indexed

About

Paul Jackson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Paul Jackson has authored 43 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 16 papers in Cellular and Molecular Neuroscience and 13 papers in Organic Chemistry. Recurrent topics in Paul Jackson's work include Peptidase Inhibition and Analysis (10 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neuropeptides and Animal Physiology (6 papers). Paul Jackson is often cited by papers focused on Peptidase Inhibition and Analysis (10 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neuropeptides and Animal Physiology (6 papers). Paul Jackson collaborates with scholars based in United States, Australia and Belgium. Paul Jackson's co-authors include Barbara S. Slusher, Brian C. Shook, Krystyna M. Wozniak, Bruce A. Donzanti, Derek C. Cole, Diane A. Trainor, Dashyant Dhanak, Kazushi Takahashi, Jie Zhang and Joel Greenberg and has published in prestigious journals such as Journal of the American Chemical Society, Nature Medicine and PLoS ONE.

In The Last Decade

Paul Jackson

41 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Jackson United States 22 809 509 407 367 195 43 1.7k
Celia Dominguez United States 27 1.1k 1.4× 412 0.8× 697 1.7× 233 0.6× 85 0.4× 79 2.2k
Chenbo Zeng United States 29 1.8k 2.2× 417 0.8× 292 0.7× 287 0.8× 119 0.6× 40 2.4k
Judith Murray‐Rust United Kingdom 29 1.7k 2.1× 693 1.4× 316 0.8× 375 1.0× 74 0.4× 83 3.4k
Shuichi Sakamoto Japan 29 2.1k 2.6× 387 0.8× 637 1.6× 661 1.8× 155 0.8× 164 3.6k
Sabrina Taliani Italy 36 1.8k 2.2× 490 1.0× 1.2k 3.0× 622 1.7× 175 0.9× 145 3.6k
Tomasz Bzdega United States 25 1.2k 1.5× 936 1.8× 74 0.2× 246 0.7× 383 2.0× 32 2.1k
Russell Dahl United States 34 1.7k 2.1× 442 0.9× 481 1.2× 351 1.0× 50 0.3× 71 2.8k
Gene M. Dubowchik United States 26 1.3k 1.6× 173 0.3× 709 1.7× 719 2.0× 596 3.1× 80 3.0k
Andrew Katsifis Australia 20 378 0.5× 179 0.4× 212 0.5× 222 0.6× 408 2.1× 59 1.3k
Carlo Bastianutto Canada 22 2.0k 2.5× 564 1.1× 99 0.2× 236 0.6× 70 0.4× 31 2.7k

Countries citing papers authored by Paul Jackson

Since Specialization
Citations

This map shows the geographic impact of Paul Jackson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Jackson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Jackson more than expected).

Fields of papers citing papers by Paul Jackson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Jackson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Jackson. The network helps show where Paul Jackson may publish in the future.

Co-authorship network of co-authors of Paul Jackson

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Jackson. A scholar is included among the top collaborators of Paul Jackson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Jackson. Paul Jackson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ehrenkaufer, Gretchen, et al.. (2023). High-throughput phenotypic screen identifies a new family of potent anti-amoebic compounds. PLoS ONE. 18(5). e0280232–e0280232. 1 indexed citations
2.
Haanes, Kristian Agmund, Alejandro Labastida‐Ramírez, Kayi Y. Chan, et al.. (2018). Characterization of the trigeminovascular actions of several adenosine A2A receptor antagonists in an in vivo rat model of migraine. The Journal of Headache and Pain. 19(1). 41–41. 19 indexed citations
3.
Vornov, James J., Kristen R. Hollinger, Paul Jackson, et al.. (2016). Still NAAG’ing After All These Years. Advances in pharmacology. 76. 215–255. 40 indexed citations
4.
Dhanak, Dashyant & Paul Jackson. (2014). Development and classes of epigenetic drugs for cancer. Biochemical and Biophysical Research Communications. 455(1-2). 58–69. 57 indexed citations
5.
Shook, Brian C., J. Kent Barbay, Aihua Wang, et al.. (2013). Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 23(9). 2688–2691. 18 indexed citations
6.
Zhang, Yuemei, et al.. (2007). Syntheses and in vitro evaluation of arylsulfone-based MMP inhibitors with heterocycle-derived zinc-binding groups (ZBGs). Bioorganic & Medicinal Chemistry Letters. 18(1). 405–408. 36 indexed citations
7.
Zhang, Yuemei, Bangping Xiang, Robert H. Scannevin, et al.. (2007). 1-Hydroxy-2-pyridinone-based MMP inhibitors: Synthesis and biological evaluation for the treatment of ischemic stroke. Bioorganic & Medicinal Chemistry Letters. 18(1). 409–413. 32 indexed citations
8.
Zhang, Yuemei, Bangping Xiang, Robert H. Scannevin, et al.. (2006). Synthesis and SAR of α-sulfonylcarboxylic acids as potent matrix metalloproteinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(12). 3096–3100. 9 indexed citations
9.
Limburg, David C., et al.. (2005). Neuroprotective Effects of Inhibitors of Dipeptidyl Peptidase-IV In Vitro and In Vivo. Kluwer Academic Publishers eBooks. 524. 351–355. 6 indexed citations
10.
Jackson, Paul, et al.. (2002). Pyridinylimidazole Based p38 MAP Kinase Inhibitors. Current Topics in Medicinal Chemistry. 2(9). 1011–1020. 43 indexed citations
11.
Jackson, Paul & Barbara S. Slusher. (2001). Design of NAALADase Inhibitors A Novel Neuroprotective Strategy. Current Medicinal Chemistry. 8(8). 949–957. 66 indexed citations
12.
Slusher, Barbara S., et al.. (2000). Suramin potently inhibits the enzymatic activity of PSM. The Prostate. 44(1). 55–60. 3 indexed citations
13.
Vornov, James J., et al.. (1999). Blockade of NAALADase: A Novel Neuroprotective Strategy Based on Limiting Glutamate and Elevating NAAG. Annals of the New York Academy of Sciences. 890(1). 400–405. 26 indexed citations
14.
Slusher, Barbara S., James J. Vornov, Ajit G. Thomas, et al.. (1999). Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury. Nature Medicine. 5(12). 1396–1402. 251 indexed citations
15.
Slusher, Barbara S., Carol W. Tiffany, Jennifer L. Olkowski, & Paul Jackson. (1997). Use of identical assay conditions for cocaine analog binding and dopamine uptake to identify potential cocaine antagonists. Drug and Alcohol Dependence. 48(1). 43–50. 33 indexed citations
16.
Takahashi, Kazushi, et al.. (1997). Neuroprotective Effects of Inhibiting Poly(ADP-Ribose) Synthetase on Focal Cerebral Ischemia in Rats. Journal of Cerebral Blood Flow & Metabolism. 17(11). 1137–1142. 134 indexed citations
17.
Slusher, Barbara S. & Paul Jackson. (1996). A shot in the arm for cocaine addiction. Nature Medicine. 2(1). 26–27.
18.
Slusher, Barbara S., et al.. (1995). Centrally-administered AMPA antagonists increase locomotion in parkinsonian rats. Journal of Neural Transmission - Parkinsons Disease and Dementia Section. 9(2-3). 145–149. 12 indexed citations
19.
Slusher, Barbara S., et al.. (1994). Centrally-administered glycine antagonists increase locomotion in monoamine-depleted mice. Journal of Neural Transmission. 97(3). 175–185. 25 indexed citations
20.
Jackson, Paul, et al.. (1976). The carbonyl group frequency. Part VI. Alkyl carbonates. Journal of the Chemical Society Perkin Transactions 2. 1800–1800. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Celia Dominguez Breakdown of academic impact, for papers by Chenbo Zeng Breakdown of academic impact, for papers by Judith Murray‐Rust Breakdown of academic impact, for papers by Shuichi Sakamoto Breakdown of academic impact, for papers by Sabrina Taliani Breakdown of academic impact, for papers by Tomasz Bzdega Breakdown of academic impact, for papers by Russell Dahl Breakdown of academic impact, for papers by Gene M. Dubowchik Breakdown of academic impact, for papers by Andrew Katsifis Breakdown of academic impact, for papers by Carlo Bastianutto
Rankless by CCL
2026